Evidence map›Paper›PMID 24424444›Full record

ArticleMolecular and cellular endocrinology2014

Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Anusha Jayaraman, Christian J Pike

Erratum issuedAbstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anusha JayaramanDavis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
Christian J PikeDavis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA. Electronic address: cjpike@usc.edu.
University of Southern California · US

Funding

Timing of Menopausal Hormone Therapy across Perimenopause to Menopause Transition: Neuroimmune System in BrainP01AG026572 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Schantel Williams · 2006 to 2026
$53.7M
NIA NIH HHS AG026572NIA NIH HHS P01 AG026572
6 · The paper itself

Abstract

Progesterone and other progestagens are used in combination with estrogens for clinical purposes, including contraception and postmenopausal hormone therapy. Progesterone and estrogens have interactive effects in brain, however interactions between synthetic progestagens and 17β-estradiol (E2) in neurons are not well understood. In this study, we investigated the effects of seven clinically relevant progestagens on estrogen receptor (ER) mRNA expression, E2-induced neuroprotection, and E2-induced BDNF mRNA expression. We found that medroxyprogesterone acetate decreased both ERα and ERβ expression and blocked E2-mediated neuroprotection and BDNF expression. Conversely, levonorgestrel and nesterone increased ERα and or ERβ expression, were neuroprotective, and failed to attenuate E2-mediated increases in neuron survival and BDNF expression. Other progestagens tested, including norethindrone, norethindrone acetate, norethynodrel, and norgestimate, had variable effects on the measured endpoints. Our results demonstrate a range of qualitatively different actions of progestagens in cultured neurons, suggesting significant variability in the neural effects of clinically utilized progestagens.

Indexed as

AnimalsCell SurvivalCerebral CortexEmbryo, MammalianEstradiolEstrogen Receptor alphaEstrogen Receptor betaGene Expression RegulationLevonorgestrelMedroxyprogesterone AcetateNeuronsNeuroprotective AgentsPrimary Cell CultureProgesterone CongenersRatsRats, Sprague-DawleyESR1 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor betaLevonorgestrelMedroxyprogesterone AcetateNeuroprotective AgentsProgesterone CongenersBDNFNeuroprotectionOestrogen receptorProgestagen

Identifiers

PMID24424444
PMCPMC3954450
OpenAlexW2156305259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.